U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 210745

OTEZLA XR (APREMILAST)
75MG
Marketing Status: Prescription
Active Ingredient: APREMILAST
Proprietary Name: OTEZLA XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 75MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N210745
Product Number: 001
Approval Date: Aug 29, 2025
Applicant Holder Full Name: AMGEN INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top